Avalo Therapeutics, Inc. (AVTX)

13.35 -0.55 (-3.96%) USD  |  NASDAQ  |  Apr 15, 16:00
13.38 +0.03 (+0.22%) Pre-Market: 20:00
More

Avalo Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for AVTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
AbbVie, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade